Which Nut Is Actually the Healthiest?

Every tree nut is fat-dominant, but the type of fat varies more than people expect. Almonds, macadamias, hazelnuts and pecans lean heavily on monounsaturated fat (MUFA) — nutritionally similar to the fat profile of olive oil — with only trace omega-3. Cashews and pistachios sit closer to a MUFA/PUFA (polyunsaturated) mix.

Walnuts are the exception: they are the only tree nut with a meaningful amount of alpha-linolenic acid (ALA), a plant-based omega-3, at roughly 2.5 g per 28 g (1 oz) serving — about half an ounce of walnuts supplies a gram of ALA. That matters because a large 2021 dose-response meta-analysis of 41 cohort studies covering nearly 1.2 million people found that each additional 1 g/day of dietary ALA was linked to a 5% lower risk of both all-cause and cardiovascular mortality, with a significant inverse association overall.¹ No other common nut gets you meaningfully closer to that intake. Macadamias, by contrast, are the most MUFA-concentrated of the tree nuts and among the lowest in polyunsaturated fat — a genuinely different fat fingerprint, not just “more of the same healthy fat.”

A systematic review of the phytochemical composition of almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts found walnuts consistently reported among the highest in total polyphenol and antioxidant capacity of the group, driven largely by ellagitannins and other polyphenolic compounds concentrated in the thin brown skin — the part people sometimes rub off, which is a mistake if antioxidant content is the goal.² Pecans test in a similar range; almonds and pistachios carry meaningful but lower polyphenol content, largely from vitamin E and carotenoids rather than the same ellagitannin class.

The honest caveat: high antioxidant content in the food does not automatically translate to a measurable rise in your blood. A 19-week randomized crossover trial giving healthy older adults 21 or 42 g of walnuts a day found no significant change in overall plasma antioxidant capacity, despite measurable improvements in a couple of individual nutrient markers.³ The compounds are there in the nut; how much of that translates into a measurable systemic effect in a healthy, already well-nourished person is a separate, less settled question.

If you are watching carbohydrate load, the nuts are not interchangeable. Per 28 g (about a small handful), cashews carry roughly 9 g of total carbohydrate — noticeably more starch than the others, since cashews are a starchier seed to begin with — and most of that carbohydrate is not fiber, so it counts fully toward blood sugar. Pistachios come next at around 8 g, but with close to 3 g of fiber built in, softening the net effect. Almonds sit in the middle at around 6 g. Walnuts, macadamias, pecans and Brazil nuts land lowest, at 3–4 g per serving, most of it fiber rather than digestible starch. For anyone managing blood sugar or eating low-carb, that makes walnuts, macadamias, pecans and Brazil nuts the most forgiving choices gram for gram, with cashews the one to actually measure rather than eyeball.

Brazil nuts and selenium. This is the clearest single-nutrient story in the whole category. A randomized controlled trial gave adults 2 Brazil nuts a day for 12 weeks, intended to supply about 100 µg of selenium; actual measured intake averaged 53 µg/day from the nuts. Plasma selenium rose 64.2% in the Brazil nut group — matching a 100 µg selenomethionine supplement (61.0%) and far outpacing placebo (7.6%) — with glutathione peroxidase activity, an antioxidant enzyme that depends on selenium, rising alongside it.⁴ No other nut supplies a nutrient this concentrated relative to a normal serving; it is also the one where more is not better; see the dose note below.

Pistachios and blood glucose. In a randomized crossover trial, 48 people with type 2 diabetes ate 25 g of pistachios twice a day as a snack for 12 weeks. Compared with the no-nut control period, HbA1c fell by 0.4 percentage points and fasting blood glucose dropped by 16 mg/dl — both statistically significant — alongside reductions in systolic blood pressure and CRP, a marker of inflammation.⁵ That is a meaningfully larger glycemic effect than has been shown for most other individual nuts in comparable trial designs.

Not on a single “best nut” — but there is strong agreement on the category. A meta-analysis of 20 prospective cohort studies covering 467,389 people found nut consumption was associated with a 27% lower risk of cardiovascular mortality and a 19% lower risk of all-cause mortality, comparing the highest to lowest intake groups.⁶ A separate dose-response meta-analysis found each additional 28 g (1 oz) of nuts eaten daily was linked to a 21% lower risk of cardiovascular disease and a 22% lower risk of all-cause mortality — and the associations held about equally for tree nuts and peanuts.⁷ The landmark PREDIMED randomized trial, which gave over 7,000 high-risk adults in Spain either a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with 30 g/day of mixed nuts, or a low-fat control diet, found the mixed-nut group had a 28% lower rate of major cardiovascular events than the control group over a median 4.8 years.⁸ Notably, that trial used mixed nuts, not one variety.

So the research consensus is really: eat nuts, mix varieties, and the exact species matters less than showing up regularly. Where researchers do lean toward a specific nut, walnut is the one most often singled out — it is the nut most frequently used as the sole variety in the largest supporting trials, and it is the only one carrying the ALA-plus-polyphenol combination described above.